FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of May, 2003
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Holding(s) in Company
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Celltech Group plc
2. Name of shareholder having a major interest
FMR Corp. and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
As in 2 above
4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
State Street Nominees Limited 147,412
Mellon Bank 13,418
Chase Nominees Limited 1,828,588
State Street Bank & Trust Company 271,400
State Street Bank & Trust 86,300
State Street Nominees Ltd 9,600
Lloyds Bank Nominees Limited 38,600
Brown Brothers Harriman 13,000
JP Morgan Chase 28,300
Northern Trust 6,800
MSCO 1,252
Morgan Stanley & Co 7,100
National Cities 7,000
Chase Nominees 6,776,745
Chase Manhattan Bank London 169,500
Chase Nominees Ltd 41,100
Citibank 136,700
Deutsche Bank 50,400
HSBC 98,814
Bank of New York London 121,800
Chase Nominees Ltd 716,320
Northern Trust 152,600
Credit Suisse FST BOS Zurich 10,800
Citibank 15,600
Chase Nominees 1,236,000
Nortrust Nominees Ltd 658,326
HSBC Client Holdings Nominee (UK) Limited 11,814,170
Chase Manhattan Bank London 628,537
Northern Trust 1,175,282
JP Morgan 362,811
Bank of New York London 1,139,400
Morgan Stanley 260,600
Deutsche Bank 189,644
Mellon Nominees Ltd 36,900
State Street Nominees Ltd 183,900
Bank of New York Brussels 407,641
State Street Bank & Trust 541,072
HSBC 32,300
National Australia Bank 12,000
PICG 6,200
Chase Manhattan Bank AG Frankfurt 30,100
Citibank 18,800
HSBC Client Holdings Nominee (UK) Limited 200
5. Number of shares / amount of stock acquired
2,090,690 (since last notification)
6. Percentage of issued class
0.75%
7. Number of shares / amount of stock disposed
N/a
8. Percentage of issued class
N/a
9. Class of security
Ordinary 50p Shares
10. Date of transaction
14 May 2003
11. Date company informed
15 May 2003
12. Total holding following this notification
29,483,032
13. Total percentage holding of issued class following this notification
10.62%
14. Any additional information
-
15. Name of contact and telephone number for queries
Anita Dowling
(01753) 777106
16. Name and signature of authorised company official responsible for making this notification
J A D Slater
Date of notification
15 May 2003
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 15 May, 2003